Background: When meningiomas are small or asymptomatic, the decision to observe rather than treat requires balancing the growth potential of the lesion with the outcome and side effects of treatment. The aim of this study is to characterize the growth patterns of untreated meningiomas to better inform the clinical decision-making process.
Methods: Patients with meningiomas were identified from 2005 to 2015. Those without treatment who had been followed for 1.5 years, with three magnetic resonance imaging (MRI) scans, were identified. Scans were measured with orthogonal diameters, geometric mean diameters, and volumes using the ABC/2 method. Regression modeling determined what growth pattern these parameters best approximated.
Results: Two hundred and fifteen MRI scans for 34 female (82.9%) and 7 male (17%) patients with 43 tumors were evaluated. Initial tumor volumes ranged from 0.13 to 9.98 mL. The mean and median initial volumes were 2.44 and 1.52 mL, respectively. Follow-up times ranged from 21 to 144 months, with a median of 70 months. There were 12 tumors (28%) whose growth rates were significantly greater than zero. For all tumors, use of a linear regression model allowed accurate prediction of the future size using prior data.
Conclusion: Three-quarters of presumptive meningiomas managed conservatively do not grow significantly. The remainder have significant growth over time, and the behavior could be approximated with linear regression models.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/s-0041-1739216 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary and salvage radiosurgery for neurofibromatosis type 2-associated meningiomas.
J Neurosurg
November 2024
1Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh.
Objective: The optimal management of neurofibromatosis type 2 (NF2)-associated meningiomas must be personalized case by case. Stereotactic radiosurgery (SRS) is one option for patients with one or multiple intracranial meningiomas associated with the NF2 mutation. In this study, the authors evaluated their single-institution experience of SRS treatment for NF2-associated meningiomas.
View Article and Find Full Text PDFAnalysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma.
Neurooncol Adv
September 2024
Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.
Article Synopsis
- Primary optic nerve sheath meningiomas (ONSMs) are benign tumors that can cause gradual vision loss, and radiation therapy, particularly proton therapy, is key for treatment as it may improve visual function while minimizing side effects.* -
- In a study of 32 patients treated with proton beam radiotherapy, results showed a 100% local control rate after 5 years and 84.4% of patients experienced improved or stable vision, despite a 9.4% occurrence of radiation-induced optic neuropathy (RION).* -
- The findings support proton beam therapy as a safe and effective option for ONSM treatment, though further research is needed to compare its effectiveness against traditional photon radiotherapy.*
Clinical, molecular, and genetic features of spinal meningiomas.
Neurooncol Adv
October 2024
Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Article Synopsis
- * Recent research indicates that spinal meningiomas have unique subtypes and genetic diversity, differing from intracranial meningiomas, even within the same WHO grades.
- * The review emphasizes the need for more studies to connect molecular, genetic, and imaging data to clinical outcomes, aiming to improve patient prognosis and treatment management.
Clinical trial design for novel targeted agents in neuro-oncology.
J Neurooncol
January 2025
Center For Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Article Synopsis
- Biomarker-based clinical trials for targeted treatments in brain tumors are increasing due to improved testing and understanding of tumor biology.
- The design of these trials is essential for assessing safety and effectiveness, especially when considering unique challenges faced by brain tumor patients.
- Trial methodologies like surgical window studies, basket and umbrella trials, and platform trials are helping to evaluate various biomarker-driven approaches while addressing issues of patient diversity and health disparities.
Neuropsychiatric Manifestations of a Frontal Lobe Meningioma: A Case Report.
Cureus
August 2024
Psychiatry, Al Amal Psychiatric Hospital, Emirates Health Services, Dubai, ARE.
The exclusion of organic causes for psychiatric symptoms is a routine practice in mental healthcare. Brain tumors can elicit a range of mood, behavioral, or cognitive symptoms that mimic mental health disorders, significantly altering a patient's personality and behavior if left undiagnosed or untreated. This case report presents a 56-year-old Middle Eastern male with no prior history of mental illness who exhibited a three-week history of depressive symptoms, social withdrawal, and poor self-care.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!